AI assistant
Sending…
Minerva Neurosciences, Inc. — Director's Dealing 2018
Sep 17, 2018
35086_dirs_2018-09-17_608d82ef-338c-4f73-85fd-2ea6ef83c135.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2018-09-13
Reporting Person: DOYLE WILLIAM F (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-09-13 | Common Stock | P | 2000 | $10.50 | Acquired | 10011 | Direct |
| 2018-09-14 | Common Stock | P | 200 | $10.50 | Acquired | 10211 | Direct |
More from Minerva Neurosciences, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Capital/Financing Update
2026
May 27
Share Issue/Capital Change
2026
May 27
Interim / Quarterly Report
2026
May 5
Earnings Release
2026
May 5
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Feb 17